A follow-up on pneumonia story

Something interesting to ponder concerning the pneumo vaxes and COVID-19 reports in VAERS

Check out the article recently posted in the Where are the Numbers Substack posted here called Whodunnit? {unabridged}.

Whodunnit? {unabridged}

Norman, Martin, Jonathan and Jessica point to a study by Lewnard et al that looked at the interaction between bacterial pneumonia and SARS-CoV-2 whereby they investigated whether vaccination against pneumonia reduced the risk of COVID-19. They found that it did and significantly so!

As the authors point out in their article above, why wouldn’t these products have been endorsed as measures against COVID-19 in that case? This study was published in May 2022. The pneumonia vaccines were already on the market right? FDA approved. Many types. Easy peasy. Offer peeps these products to reduce COVID-19 risk. Why not. You’re recommending RunDeathIsNear, I mean Remdesivir, so why not an FDA-approved product shown to reduce risk.

The pneumonia vaccines in their study included two products: pneumococcal vaccination (13-valent conjugate vaccine [PCV13] and 23-valent pneumococcal polysaccharide vaccine [PPSV23]).

I decided, like I always do, to see what’s going on in VAERS. In this case, I looked with regard to adverse event (AE) reports of COVID-19 in the context of any and all vaccines against pneumonia for 2021-2023. I found something interesting.

It’s been well-known to me (and anyone looking) for years now that the number reported AE in VAERS in the context of the COVID-19 products is COVID-19. But what’s the story with the pneumonia vaccines?

The reported AEs in the context of vaccines aimed at pneumonia in VAERS are in the context of 4 products that I will list verbatim from the VAERS variable VAX_NAME: ‘PNC’, ‘PNC10’, ‘PNC13’ and ‘PPV’.

The names are different in VAERS as in the literature, so I checked the manufacturing names against the brand names¹ and found out that PNC10 = synflorix² = PCV10 and PNC13 = prevnar13³ = PCV13. PPV = pneumovax and PPSV23 = pneumovax 23⁴, so I assume these are the same. As for PNC alone, this could refer to any of valencies of the pneumococcal vaccines. I am not sure. For the purposes of this investigation, it doesn’t matter since there are no reports in VAERS in the context of COVID-19 as a symptom for this product.

Now I am not saying that we can really conclude anything here, but it is interesting that considering it has been shown that the pneumococcal vaccines reduce COVID-19 risk and that these products were not deployed during the COVID-19 war to fight COVID-19, that there are very few reports of COVID-19 associated with them. Maybe, just maybe, these products work to stave off ‘COVID-19’? I wonder.

As previously mentioned, COVID-19 is the number 1 reported AE in the context of the COVID-19 products so this is in stark and statistically significant (p <= 0.000001) contrast to the above. In fact 15% of the AE reports in the context of both the mono- and bivalent products are COVID-19, and this is opposed to 0.73% in the context of the pneumonia vaccines.

Now, I am not saying that the pneumonia vaccines should have been pushed - basically because I know nothing about them yet - but I am wondering is why they weren’t pushed. Why were the COVID-19 products, those safe and effective EUA products, those experimental transfecting products, pushed so hard onto the public? Why were regular antibiotics not prescribed? Why do we call the Spanish flu the Spanish flu? Why the insistence, even today, to get injected with this novel technology - the modified mRNA platform - that has clearly been shown to have negative efficacy in the context of ‘COVID-19’?

They don’t work.

(N.B. I am NOT promoting the pneumonia products! I am simply being a rebel bitch and forcing answers to questions that have no answers. :) )

Maybe COVID-19 is pneumonia.

1. https://www.uptodate.com/contents/pneumococcal-vaccination-in-adults/print

2. https://gskpro.com/content/dam/global/hcpportal/en_CA/products/synflorix/pdf/Synflorix_Fact_Sheet_Eng.pdf

3. https://www.fda.gov/files/vaccines,%20blood%20&%20biologics/published/Package-Insert------Prevnar-13.pdf

4. https://www.merckvaccines.com/pneumovax23/